Shield Therapeutics plc filed its Annual on May 22, 2020 for the period ending Dec 31, 2019. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.